210 related articles for article (PubMed ID: 26799157)
1. A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition.
Murray B; Sorci M; Rosenthal J; Lippens J; Isaacson D; Das P; Fabris D; Li S; Belfort G
Proteins; 2016 Apr; 84(4):488-500. PubMed ID: 26799157
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation.
Das P; Murray B; Belfort G
Biophys J; 2015 Feb; 108(3):738-47. PubMed ID: 25650940
[TBL] [Abstract][Full Text] [Related]
3. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
[TBL] [Abstract][Full Text] [Related]
4. Dimerization Mechanism of Alzheimer Aβ
Nguyen PH; Sterpone F; Pouplana R; Derreumaux P; Campanera JM
J Phys Chem B; 2016 Dec; 120(47):12111-12126. PubMed ID: 27933940
[TBL] [Abstract][Full Text] [Related]
5. The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu
Somavarapu AK; Shen F; Teilum K; Zhang J; Mossin S; Thulstrup PW; Bjerrum MJ; Tiwari MK; Szunyogh D; Søtofte PM; Kepp KP; Hemmingsen L
Chemistry; 2017 Oct; 23(55):13591-13595. PubMed ID: 28815875
[TBL] [Abstract][Full Text] [Related]
6. The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.
Benilova I; Gallardo R; Ungureanu AA; Castillo Cano V; Snellinx A; Ramakers M; Bartic C; Rousseau F; Schymkowitz J; De Strooper B
J Biol Chem; 2014 Nov; 289(45):30977-89. PubMed ID: 25253695
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Protective Cross-Interaction between Wild-Type and A2T Variants Alters Aβ
Das P; Chacko AR; Belfort G
ACS Chem Neurosci; 2017 Mar; 8(3):606-618. PubMed ID: 28292185
[TBL] [Abstract][Full Text] [Related]
8. Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2018 Feb; 36(2):407-422. PubMed ID: 28054501
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors.
Chakraborty S; Das P
Sci Rep; 2017 Aug; 7(1):9941. PubMed ID: 28855598
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity.
Lin TW; Chang CF; Chang YJ; Liao YH; Yu HM; Chen YR
PLoS One; 2017; 12(3):e0174561. PubMed ID: 28362827
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction.
Colombo L; Gamba A; Cantù L; Salmona M; Tagliavini F; Rondelli V; Del Favero E; Brocca P
Biophys Chem; 2017 Oct; 229():11-18. PubMed ID: 28502484
[TBL] [Abstract][Full Text] [Related]
12. Weaker N-Terminal Interactions for the Protective over the Causative Aβ Peptide Dimer Mutants.
Sharma B; Ranganathan SV; Belfort G
ACS Chem Neurosci; 2018 Jun; 9(6):1247-1253. PubMed ID: 29465978
[TBL] [Abstract][Full Text] [Related]
13. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease.
Lee MC; Yu WC; Shih YH; Chen CY; Guo ZH; Huang SJ; Chan JCC; Chen YR
Sci Rep; 2018 Mar; 8(1):4772. PubMed ID: 29555950
[TBL] [Abstract][Full Text] [Related]
14. Folding stability of amyloid-beta 40 monomer is an important determinant of the nucleation kinetics in fibrillization.
Ni CL; Shi HP; Yu HM; Chang YC; Chen YR
FASEB J; 2011 Apr; 25(4):1390-401. PubMed ID: 21209058
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations to investigate the aggregation behaviors of the Abeta(17-42) oligomers.
Zhao JH; Liu HL; Liu YF; Lin HY; Fang HW; Ho Y; Tsai WB
J Biomol Struct Dyn; 2009 Feb; 26(4):481-90. PubMed ID: 19108587
[TBL] [Abstract][Full Text] [Related]
16. Impact of the A2V Mutation on the Heterozygous and Homozygous Aβ1-40 Dimer Structures from Atomistic Simulations.
Nguyen PH; Sterpone F; Campanera JM; Nasica-Labouze J; Derreumaux P
ACS Chem Neurosci; 2016 Jun; 7(6):823-32. PubMed ID: 27007027
[TBL] [Abstract][Full Text] [Related]
17. Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking.
Jiang D; Rauda I; Han S; Chen S; Zhou F
Langmuir; 2012 Sep; 28(35):12711-21. PubMed ID: 22870885
[TBL] [Abstract][Full Text] [Related]
18. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
[TBL] [Abstract][Full Text] [Related]
19. Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity.
Diomede L; Di Fede G; Romeo M; Bagnati R; Ghidoni R; Fiordaliso F; Salio M; Rossi A; Catania M; Paterlini A; Benussi L; Bastone A; Stravalaci M; Gobbi M; Tagliavini F; Salmona M
Neurobiol Dis; 2014 Feb; 62():521-32. PubMed ID: 24184799
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic Origin of Amyloid Aggregation: Collective Effects of the Mutation and Tautomerism of Histidine.
Li H; Salimi A; Lee JY
ACS Chem Neurosci; 2019 Nov; 10(11):4729-4734. PubMed ID: 31600048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
